Evidence map›Paper›PMID 36571615›Full record

ArticleAdvances in biochemical engineering/biotechnology2023

Process Technologies of Cyanobacteria.

Marco Witthohn, Dorina Strieth, Jonas Kollmen, Anna Schwarz, Roland Ulber, Kai Muffler

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in biochemical engineering/biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marco WitthohnDepartment of Life Sciences and Engineering, University of Applied Sciences Bingen, Bingen, Germany.
Dorina StriethChair of Bioprocess Engineering, Technical University of Kaiserslautern, Kaiserslautern, Germany.
Jonas KollmenChair of Bioprocess Engineering, Technical University of Kaiserslautern, Kaiserslautern, Germany.
Anna SchwarzDepartment of Life Sciences and Engineering, University of Applied Sciences Bingen, Bingen, Germany.
Roland UlberChair of Bioprocess Engineering, Technical University of Kaiserslautern, Kaiserslautern, Germany. ulber@mv.uni-kl.de.
Kai MufflerDepartment of Life Sciences and Engineering, University of Applied Sciences Bingen, Bingen, Germany.
TH Bingen University of Applied Sciences · DEUniversity of Kaiserslautern · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the handling and exploitation of cyanobacteria is associated with some challenges, these phototrophic bacteria offer great opportunities for innovative biotechnological processes. This chapter covers versatile aspects of working with cyanobacteria, starting with up-to-date in silico and in vitro screening methods for bioactive substances. Subsequently, common conservation techniques and vitality/viability estimation methods are compared and supplemented by own data regarding the non-invasive vitality evaluation via pulse amplitude modulated fluorometry. Moreover, novel findings about the influence the state of the pre-cultures have on main cultures are presented. The following sub-chapters deal with different photobioreactor-designs, with special regard to biofilm photobioreactors, as well as with heterotrophic and mixotrophic cultivation modes. The latter topic provides information from literature on successfully enhanced cyanobacterial production processes, augmented by own data.

Indexed as

CyanobacteriaBiotechnologyPhotobioreactorsCell characterizationCyanobacteriaMixo-/Heterotrophic cultivationPhotobioreactorsStrain conservation

Identifiers

PMID36571615
OpenAlexW4312195097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.